Does the hon. Gentleman understand the danger of undermining our clinical trials systems, in that, using the Bill, a doctor would have to convince only one colleague before they could go ahead and try something completely new? The recent tragedy of the patient who died while taking part in a phase 1 trial shows the need for steps and procedures to reduce the risk.
Access To Medical Treatments (Innovation) Bill
Proceeding contribution from
Philippa Whitford
(Scottish National Party)
in the House of Commons on Friday, 29 January 2016.
It occurred during Debate on bills on Access To Medical Treatments (Innovation) Bill.
About this proceeding contribution
Reference
605 c550Session
2015-16Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2021-11-04 13:29:54 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2016-01-29/16012937000178
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2016-01-29/16012937000178
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2016-01-29/16012937000178